Dyne Therapeutics, Inc. Common Stock, Shares, Outstanding from Q4 2019 to Q3 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Dyne Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2019 to Q3 2025.
  • Dyne Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2025 was 143M shares, a 40.2% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)

Dyne Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 143M +40.9M +40.2% Sep 30, 2025 10-Q 2025-11-05
Q2 2025 114M +14.2M +14.2% Jun 30, 2025 10-Q 2025-07-28
Q1 2025 114M +26.5M +30.5% Mar 31, 2025 10-Q 2025-05-08
Q4 2024 102M +40.8M +66.5% Dec 31, 2024 10-Q 2025-11-05
Q3 2024 102M +40.4M +65.9% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 100M +39.1M +64.1% Jun 30, 2024 10-Q 2024-08-12
Q1 2024 87.1M +28.8M +49.4% Mar 31, 2024 10-Q 2024-05-02
Q4 2023 61.5M +5.83M +10.5% Dec 31, 2023 10-K 2025-02-27
Q3 2023 61.3M +9.42M +18.1% Sep 30, 2023 10-Q 2023-10-30
Q2 2023 61M +9.28M +17.9% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 58.3M +6.66M +12.9% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 55.6M +4.07M +7.89% Dec 31, 2022 10-K 2024-03-05
Q3 2022 51.9M +423K +0.82% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 51.7M +502K +0.98% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 51.6M +491K +0.96% Mar 31, 2022 10-Q 2022-05-02
Q4 2021 51.6M +6.49M +14.4% Dec 31, 2021 10-K 2023-03-02
Q3 2021 51.5M +6.48M +14.4% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 51.2M Jun 30, 2021 10-Q 2021-08-05
Q1 2021 51.2M Mar 31, 2021 10-Q 2021-05-06
Q4 2020 45.1M +42.5M +1643% Dec 31, 2020 10-K 2022-03-10
Q3 2020 45M Sep 30, 2020 10-Q 2020-11-05
Q4 2019 2.59M Dec 31, 2019 10-K 2021-03-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.